The North American Spine Society (NASS) Annual Meeting is the gathering with arguably the greatest ability to influence the global market for spinal implants and devices, its innovation and growth. T3 Labs Orthopedic Program Director Dr. Evan Goldberg, a long-time veteran of this industry-leading spine conference, will be onsite at NASS 2019 in Chicago on September 25-28.

“Catching up with our preclinical testing sponsors and learning about their latest developments and products in the pipeline is a highlight of NASS for me,” Evan said. “It is the place to learn about the latest trends in the field including new devices, biologics and surgical techniques. All of the clinicians, all of the big players and hundreds of innovators evaluating their readiness for a preclinical journey for their orthopedic medical devices are there.”

T3 Labs is an industry-leading preclinical CRO that provides orthopedic and spine sponsors what you need when you need it throughout your journey from proof of concept to first-in-man for their innovative therapies. 

“We are grateful to T3 Labs for providing access to the facilities and resources the team needed to be ready for our first ever preclinical session with a practicing anesthesiologist. There we acquired the customer feedback and functional performance data needed to keep us moving forward efficiently on the complex pathway from concept to commercialization.” – Cassidy Wang, Co-Founder of Ethos Medical (previously Neuraline). Read More. 

Our relationships with partners like the Emory Orthopedics and Spine Center and the Georgia Institute of Technology Petit Institute for Bioengineering and Biosciences allows us to expedite orthopedic device testing programs. These relationships also bring deep knowledge and create seamless simplicity and economy for orthopedic and spine innovators via one preclinical CRO engagement. 

“T3 Labs’ prowess for preclinical research including its surgical suite, animal husbandry infrastructure, experimental expertise and microCT imaging capabilities is outstanding. I feel that T3 Labs’ preclinical imaging like microCT, supplemented by quantitative software-driven image analysis provided by ImageIQ, is a high-value investment capable of accelerating the time-to-market for medical devices and biologics.” – Brett Hoover, Vice President, ImageIQ 

Related: Can advanced medical imaging like microCT accelerate preclinical trials? 

From concept to commercialization, complete the circle with proven bioskills training programs

Once your product is on the market, GCMI/T3 Labs can help you come full circle with our physician and sales force bioskills training programs. Whether your product has just been or is about to be approved or you are at the very early stage of device development seeking your customer feedback, we can help you translate rapidly between device testing and regulatory approval ultimately helping you convert sales.

Connect with us at NASS 2019! 

To learn more about GCMI and T3 Lab’s capabilities in preclinical medical device testing and training, connect with Evan Goldberg onsite at NASS 2019 September 25-28 via email:

Be sure to follow GCMI/T3 Labs on LinkedIn and Twitter as well!